Global regulators stress need for robust evidence on COVID-19 treatments

The report presents the outcomes of a regulatory workshop on COVID-19 therapeutic medicine development. It emphasises that no medicine has yet clearly demonstrated efficacy in treating COVID-19, and that RCTs with an appropriate control are needed to generate the necessary data.


European Medicines Agency